The First CDH1 Gene Mutation Gastric Cancer Case in Kazakhstan: Implications for Genetic Screening; A Letter to the Editor
نویسندگان
1 Department of Oncology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
2 Department of Oncology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
3 National Center for Biotechnology, Astana, Kazakhstan
4 Department of Pharmacology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
5 Department of Oncology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
6 Department of Oncology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
7 Department of Oncology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
8 Department of Oncology, West Kazakhstan Marat Ospanov Medical University, Aktobe, Kazakhstan
doi
10.30476/ijms.2025.104223.3778چکیده
Despite significant advances in medicine, food preservation methods, and Helicobacter pylori (H. pylori) treatment, gastric cancer remains the fifth most common type of cancer and the fourth leading cause of cancer-related deaths worldwide, accounting for over a million new cases and nearly 770,000 deaths in 2020.